RegenBio Summit: Transforming Next-Gen Biotherapeutics 2024 - Live Only

Ponte Vedra Beach, FL US
December 9, 2024 to December 11, 2024

Course Directors: Julie G. Allickson, Ph.D., Saranya P. Wyles, M.D., Ph.D., and Praneetha R. Elugunti, M.H.A., M.B.A.

December 9 - December 11, 2024 - Ponte Vedra Inn & Club - Ponte Vedra Beach, Florida

The RegenBio Summit is a gathering of thought leaders and experts at the forefront of regenerative medicine, biomanufacturing, and translational research. This dynamic event aims to accelerate the transformation of next-generation biotherapeutics. Our focus extends across diverse medical specialties, including orthopedics, oncology, cardiovascular medicine, neurosciences, and transplantation, among other medical and surgical specialties. This summit focuses on advancing pioneering regenerative biotherapies, setting the stage for a new era of medical and surgical possibilities.

All RegistrantsOn or before October 14, 2024After October 14, 2024
 $775$875


Abstracts

As part of the RegenBio Summit: Transforming Next-Gen Biotherapeutics 2024, trainees are invited to submit an abstract for presentation of original research dedicated to the field of Regenerative Medicine. Projects can be clinical or laboratory based. Abstracts should be 1,750 words or less.

Apply Here - Deadline to submit is September 1, 2024 at 11:59 CST

Target Audience

This course is designed for researchers, physicians, resident fellows, and medical students interested in regenerative medicine.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe fundamental principles of regenerative medicine that are being used to provide regenerative solutions to patients.
  • Review the process leading to clinical utilization of regenerative therapeutics.
  • Summarize steps to bring discovery into the community through commercialization and outreach.
  • Identify the challenges to effective delivery of regenerative therapeutics.
  • Describe the current state of the field of organ manufacturing.
  • Examine the most recent solutions adopted in the fields of regenerative science.


Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 10.25 AMA PRA Category 1 Credit
  • 10.25 Attendance
Event starts: 
12/09/2024 - 9:00am
Event ends: 
12/11/2024 - 3:30pm
Cost:
$775.00

PDF/Printable Version

RegenBio Summit: Transforming Next-Gen Biotherapeutics 2024

Ponte Vedra Beach, Florida

December 9, 2024 to December 11, 2024

Eastern Standard Time

 

Day 1

Monday, December 9, 2024

8:00 AM

Breakfast, Registration & Exhibits

9:00 AM

Welcome Announcements
Julie G. Allickson, Ph.D. and Saranya P. Wyles, M.D., Ph.D.

 

 

9:15 AM

Keynote: Regulating Regenerative Therapies from IND to BLA
Peter Marks, M.D., Ph.D.

9:30 AM

Fireside Chat: Mistakes and Lessons Learned from FDA CBER Director's Desk. An Insight into Accelerated Approval Pathways
Moderator: Julie G. Allickson, Ph.D.

10:00 AM

Genetically Engineered Cells Panel  
Moderators: Michael P. Gustafson, Ph.D.

10:30 AM

Break and Exhibits

Tissue Engineering Plenary
Moderators: David G. Lott, M.D. and Anthony J. Windebank, M.D.

11:00 AM

Sculpting Sound: 3D Bioprinting the Larynx 
David G. Lott, M.D.

11:15 AM

Can We Grow a Personalized Heart
Doris Taylor, Ph.D.

11:30 AM

To be announced

11:45 AM

Biologically Inspired Engineering Strategies to Treat Vascular Injury and Tissue Fibrosis
Jae-Won Shin, Ph.D.

12:00 PM

Panel Discussion

12:30 PM

Fireside Chat: Exosomes, Are We There Yet?
Atta Behfar, M.D., Ph.D.

1:00 PM

Lunch

2:30 PM

Fireside Chat: Impact of Generative Artificial Intelligence on Cell and Gene Therapy
Moderator: Peter A. Noseworthy, M.D., M.B.A.

Joel Greshock

3:00 PM

To be announced

3:10 PM

Writing DNA with RNA: Genome Engineering by Target Primed Reverse Transcription
Mandhusudan Peshwa, Ph.D.

3:20 PM

To be announced
 

3:30 PM

Break and Exhibits

4:00 PM

Defining the Issues: FDA Approach to Centralized, Decentralized, and Point of Care Manufacturing
Richard McFarland, M.D., Ph.D.

4:30 PM

To be announced

5:00 PM

Closing Comments

5:30 PM

Welcome Reception

 

Day 2

Tuesday, December 10, 2024

8:00 AM

Breakfast with Experts

 

FDA Unveiled: Navigating U.S. Regulations and Regulators
Drew M. Witter, M.S., RAC

 

Harmonizing Excellence: A Global Odyssey to Meet GMP Requirements
Richard McFarland, M.D., Ph.D.

 

Process Development 101
Cynthia E. Wilkins, Ph.D.

 

Advanced Biomanufacturing 101
Snigdha Rai

 

Quality Control 101
Tony W. DeFusco

 

 

Quality Assurance 101
Cameron E. Jones

9:30 AM

Fireside Chat: iPSC Readiness
Dennis Wigle, M.D., Ph.D. and Timothy Nelson, M.D., Ph.D.

10:00 AM

Morning Break

10:30 AM

Keynote: Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa – First FDA-Approved Topical Gene Therapy  
M. Peter Marinkovich, M.D.


 

10:50 AM

Fireside Chat: Mistakes and Lessons Learned from Startups.  An Insight into the Success Path of Krystal Biotech, Inc. 
Moderator: Saranya P. Wyles, M.D., Ph.D.

 

11:15 AM

Business of Regenerative Medicine
Manu Nair

11:40 AM

Mayo MedTech Accelerator: The Future of Cell and Gene Therapy
Marianne Van Der Steen

12:00 PM

Lunch/Exhibits

Cell and Gene Therapy Plenary
Moderator: Maliha Zahid, M.B.B.S., Ph.D. and Sanjay Misra, M.D.

1:30 PM

Gene or Cell Therapy for Cardiovascular Applications
Sanjay Misra, M.D.

1:45 PM

To be announced

2:00 PM

To be announced

2:15 PM

The Allure of Biomanufacturing Tregs for Inflammatory Bowel Disease
William Faubion, M.D.

2:30 PM

Panel Discussion

3:00 PM

Afternoon Break

3:30 PM

Healthcare Innovation – Think Tank Fast Pitch 
Charles J. Bruce, M.B., Ch.B.

5:00 PM

Poster Session & Networking

6:00 PM

Adjourn

 

Day 3

Wednesday, December 11, 2024

8:00 AM

Breakfast and Exhibits

9:00 AM

Keynote: Exploring the Promise of CRISPR Therapeutics In Vivo and Cell Therapy Applications
Birgit Schultes, Ph.D.

9:30 AM

To be announced
 

10:00 AM

Roundtable: Opportunities and Challenges for Regenerative Healthcare in the Future
Moderator: Julie Allickson, Ph.D.

Miguel Forte, Ph.D.

10:30 AM

Panel: Ethics in Regenerative Biotherapeutics
Moderators: Michelle McGowan, Ph.D. and Megan Allyse, Ph.D.

11:15 AM

Morning Break

iPSC Therapy Plenary

11:30 AM

To be announced

11:45 AM

A Vision to Grow Stem Cells into Retinal Pigment Epithelium (RPE) for Eyesight
Kapil Bharti, Ph.D.

12:00 PM

To be announced

12:15 PM

Panel Discussion

12:30 PM

Lunch and Exhibits

Immunotherapy Plenary
Moderators: Saad J. Kenderian, M.B., Ch.B.

1:30 PM

Current Challenges in CAR-T Cell Therapy and Role of Tumor Microenvironment
Saad J. Kenderian, M.B., Ch.B.

1:45 PM

Transforming Lives with Personalized Cancer Therapies
Bruce Levine, Ph.D.  

2:00 PM

Managing CAR-T Cell Therapy in the Real World
Yi Lin, M.D., Ph.D.

2:15 PM

Panel Discussion

2:30 PM

Addressing Challenges in Translation and Commercialization of Cell and Gene Therapies
Uma Lakshmipathy, Ph.D.

3:00 PM

Adjourn

Ponte Vedra Inn & Club
200 Ponte Vedra Boulevard
Ponte Vedra Beach, FL 32082
United States

A limited block of guest rooms has been reserved at a special group rate of $329 (USD), per night, plus tax and a daily resort service charge of $20. To receive the special group rate, please identify yourself as a registrant of the Mayo Clinic RegenBio Summit and make your reservation before the room block is filled or by the expiration date of November 7, 2024. You may reserve your room by calling the hotel directly at 1-800-234-7842 or clicking the Reservation Link below.

Any applicable Florida State sales tax (currently 6.5%), St. John’s County resort tax (currently 5.0%), or other applicable taxes (if any) will be added to the total of all charges, including but not limited to the Resort Fee.

Reservation Link

All travel and lodging expenses are the sole responsibility of the individual registrant.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

DayCredits
Monday3.25
Tuesday4.25
Wednesday2.75

 

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 10.25 AMA PRA Category 1 Credit
  • 10.25 Attendance

For information regarding exhibit opportunities, please reach out to Kristy Badder.

Price

Cost:
$775.00
Please login or register to take this course.

 


Please update your profile to let us know if you have dietary restrictions or access requirements. 


Commitment to Equity, Diversity and Inclusion​ 

Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.  ​ 


 

Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.